Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001413428 | SCV001615542 | likely benign | Pancreatic adenocarcinoma | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038105 | SCV003737681 | uncertain significance | not specified | 2022-06-28 | criteria provided, single submitter | clinical testing | The c.457C>T (p.P153S) alteration is located in exon 2 (coding exon 1) of the PALLD gene. This alteration results from a C to T substitution at nucleotide position 457, causing the proline (P) at amino acid position 153 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |